What DBS Can and Cannot Improve in Parkinson Disease: Tremor, Stiffness and Fluctuations

The kitchen clock says 2:40. Her last dose kicked in around noon, and for ninety good minutes she chopped onions, texted her grandson and forgot she had Parkinson disease. Now the tremor has crept back into her right hand, her left foot drags on the tile, and the next dose is not due for over an hour. Her neurologist has raised the idea of deep brain stimulation twice. She keeps circling one question: what dbs can and cannot improve, honestly, without the brochure gloss.

That question deserves a precise answer, because DBS is neither the miracle some online forums describe nor the last-resort gamble others fear. It is a well-studied treatment with a fairly predictable profile: strong for some symptoms, weak for others, and irrelevant to a few.

This explainer walks through that profile symptom by symptom, using the same evidence movement disorders teams use when they sit down with patients and families.

What DBS can and cannot improve: the one rule that explains most of it

Specialists lean on a single principle when they predict what dbs can and cannot improve for a given person: with the notable exception of tremor, DBS tends to help the symptoms that levodopa helps, and it tends to leave alone the symptoms that levodopa leaves alone.

Levodopa is the generic name for the medicine the brain converts into dopamine, the chemical messenger lost in Parkinson disease. When someone takes it and their stiffness melts, their steps lengthen and their hand steadies, those symptoms are said to be dopamine-responsive. According to the National Institute of Neurological Disorders and Stroke (NINDS), DBS is most effective for exactly those features: tremor, rigidity, slowness and the fluctuating response to medication that develops over years of treatment.

The flip side matters just as much. Symptoms that persist even when medication is working at its best, such as poor balance, freezing of gait mid-stride, soft or slurred speech, swallowing trouble, constipation, memory changes and low mood, arise from brain circuits that dopamine does not fully control. Stimulating the movement circuits does not repair them.

Why does this rule hold? DBS delivers tiny electrical pulses to a pea-sized structure deep in the brain, usually the subthalamic nucleus or the globus pallidus interna, both part of the network that goes haywire when dopamine runs short. The pulses quiet the abnormal firing in that network. They do not add dopamine, and they do not reach the brainstem and cortical regions responsible for balance, speech and thinking.

Hold that rule in mind through the rest of this article. Nearly every “can” and “cannot” below follows from it, and it is the reason a good DBS evaluation begins not with a scan but with a careful test of how you move with and without your medication.

How deep brain stimulation actually works

Picture a pacemaker for a very specific patch of brain. That is the mental model most neurosurgeons offer, and it holds up well.

The system has three parts. One or two thin insulated wires, called leads, are placed so their tips rest in the target nucleus. A small battery-powered device, the pulse generator, sits under the skin below the collarbone, roughly the size of a matchbox. A connecting wire runs under the skin of the neck and scalp to join them. The Mayo Clinic describes the generator as sending continuous electrical pulses that modify the abnormal signals causing symptoms.

Placement is the exacting part. Surgeons use detailed MRI and CT imaging, a head frame or frameless guidance, and often live recordings of individual brain cells to confirm the tip sits in the right spot. Many centers keep the person awake for part of the operation so they can move a hand or speak while the team tests stimulation and watches for unwanted effects. Others perform the procedure fully asleep using imaging alone. Both approaches are standard; the choice depends on the center and the individual.

Nothing is destroyed. Unlike older lesioning operations that burned a tiny hole in the target, DBS is adjustable and reversible. A clinician holding a programmer tablet can change which contacts on the lead are active, how strong the pulse is and how often it fires, all through the skin, without another operation.

What the pulses are doing at the cellular level is still debated. The leading explanation, summarized by Johns Hopkins Medicine, is that high-frequency stimulation overrides the chaotic, overly synchronized firing in the motor loop, effectively jamming a bad signal rather than adding a good one. That mechanism explains both the strengths and the limits described in the sections that follow.

DBS for Parkinson's tremor, stiffness and slowness: what usually changes

Tremor is the symptom people see, and it is the one where DBS often earns its reputation. It is also the exception to the levodopa rule: some tremor responds poorly to medication yet still settles with stimulation. NINDS lists tremor first among the symptoms DBS is designed to address, and NHS guidance notes that DBS is used when tremor and other motor symptoms are no longer adequately controlled by medicines.

The typical experience reported in clinic is that resting tremor on the side opposite the stimulated brain hemisphere becomes markedly quieter, sometimes within minutes of the device being switched on. Because each side of the brain controls the opposite side of the body, people with tremor in both hands generally need leads on both sides.

Rigidity, the stiffness that makes an arm feel like a rusty hinge when a clinician bends it, is also strongly dopamine-responsive and usually improves in parallel with tremor. People often describe it as their limbs feeling “oiled” again.

Bradykinesia, the medical term for slowness and smallness of movement, is subtler. Handwriting may grow larger, buttoning may speed up and turning in bed may become easier. The gains here are real but tend to be more modest than the tremor response, and they track closely with how much slowness the person’s best medication dose was already relieving.

Two caveats keep expectations honest. First, DBS treats the symptom, not the disease, so tremor and slowness that would have worsened over the coming years may still slowly progress beneath the stimulation, requiring periodic reprogramming. Second, the result depends heavily on lead placement, which is why the evaluation and surgical planning stages matter more than the operation itself.

Motor fluctuations and dyskinesia: smoothing the on-off cycle

For many people, tremor is not the reason they are referred for DBS. The real driver is the roller coaster.

After several years on levodopa, the smooth, day-long benefit many people enjoy early on tends to fragment. Doses wear off sooner, a phenomenon called wearing-off, so that a person might be moving well at 10 a.m. and struggling to rise from a chair by 11:30. Some doses switch on unpredictably or not at all. Meanwhile, the peaks of medication can bring dyskinesia, the involuntary writhing or dancing movements that are a side effect of treatment rather than a symptom of Parkinson disease. Mayo Clinic identifies these fluctuating responses to medication as a core reason DBS is considered.

Here DBS has two distinct effects. Directly, stimulation provides a steady background of symptom control that does not depend on when the last tablet was swallowed, so the “off” troughs become shallower and shorter. Indirectly, many people are able, under their neurologist’s supervision, to have their medication regimen adjusted after surgery, which can reduce the peak-dose dyskinesia that medicine alone was producing. Stimulation of the globus pallidus interna target can also dampen dyskinesia directly, which is one reason teams sometimes choose it.

The practical result people describe is a more predictable day: fewer hours spent waiting for a dose to work, fewer hours lost to involuntary movements, and less anxiety about timing every meal and outing around the medication clock.

Any change to medicines after DBS is a clinical decision made by the treating team over weeks to months, not a fixed expectation. Some people continue on much the same regimen; the device and the medicine are partners, not competitors.

Does DBS help balance, freezing and falls?

This is where the conversation gets harder, and where honest counseling matters most.

Postural instability, the tendency to lose balance and fall, and freezing of gait, the sudden sensation that the feet are glued to the floor, are among the most disabling features of advancing Parkinson disease. They are also, in most cases, among the least dopamine-responsive. If a person still freezes or sways when their medication is working at its best, that is a strong signal that DBS is unlikely to fix those particular problems.

The reason traces back to anatomy. Balance and gait initiation depend on brainstem circuits and on widespread cortical networks, not only on the basal ganglia loop where the DBS lead sits. Stimulating the subthalamic nucleus or globus pallidus can indirectly help walking that was fluctuating with medication, because a person who is no longer stuck in prolonged “off” periods walks more steadily overall. That is different from repairing a balance system that fails even during good “on” time.

Cleveland Clinic and Mayo Clinic both list problems with balance or walking among the possible side effects of DBS, not only among its limitations. In some people, particularly with subthalamic stimulation, gait or postural control can worsen slightly, and programmers may need to trade a little tremor benefit for steadier walking.

So does DBS help balance? Occasionally and indirectly, when imbalance was really a symptom of being “off.” Rarely and unreliably when imbalance persists at the person’s best. Anyone considering DBS chiefly to stop falling should raise that goal explicitly with the team, because the evidence does not support it as a primary reason for surgery. Physical therapy, gait training and home safety measures remain the mainstays for this part of the illness.

Speech, swallowing, thinking and mood: the honest picture

Ask a room of people living with DBS what surprised them, and speech comes up often.

Hypophonia, the soft voice common in Parkinson disease, and dysarthria, the slurring or mumbling that can accompany it, are only partly dopamine-responsive. DBS does not usually improve them, and in a proportion of people speech becomes somewhat softer or less clear after surgery. Mayo Clinic lists speech problems among recognized side effects. Programmers can often reduce this by adjusting which contacts are active or lowering intensity, but the adjustment may cost a little motor benefit. Speech therapy remains the primary treatment for voice changes before and after surgery.

Swallowing difficulty, or dysphagia, follows a similar pattern: not a target of DBS, and occasionally slightly worsened by it.

Cognition is the most emotionally charged topic. DBS does not treat memory loss or the slowed thinking that can develop in Parkinson disease, and people with established dementia are generally not offered the procedure because of the risk of confusion afterward and limited benefit. In people without dementia, large studies summarized by NINDS show that most maintain their overall cognitive function, though some experience declines in verbal fluency, the ability to quickly produce words, which is the domain most consistently affected.

Mood and behavior need watching. Depression, anxiety and apathy are common in Parkinson disease regardless of surgery. After DBS, some people feel emotionally flatter for a period, a few become impulsive, and mood changes in either direction can follow rapid medication adjustments. Cleveland Clinic lists mood changes among possible effects. None of these are reasons to dismiss DBS, but they are reasons every good program includes a neuropsychologist and screens carefully for untreated depression before surgery.

Non-motor symptoms such as constipation, urinary urgency, low blood pressure on standing and sleep disturbance are not expected to improve with stimulation, although better nights sometimes follow from less tremor and rigidity in bed.

What DBS can and cannot improve at a glance

The table below condenses the evidence discussed so far. It reflects general patterns described by NINDS, Mayo Clinic, Cleveland Clinic and Johns Hopkins Medicine; individual results vary with lead placement, target, disease stage and programming.

Symptom	Usual response to DBS	Why
Resting tremor	Often improves substantially, even when medication helped little	Tremor circuits sit within the stimulated network
Rigidity (stiffness)	Usually improves	Strongly dopamine-responsive
Bradykinesia (slowness)	Usually improves, often more modestly	Dopamine-responsive; tracks best “on” state
Wearing-off and “off” periods	Usually shortened and smoothed	Steady stimulation does not depend on dose timing
Dyskinesia	Often reduced, directly or via medication adjustment	Pallidal target dampens it; lower peaks after regimen changes
Balance and falls	Generally not improved; may worsen in some	Brainstem and cortical circuits outside the target
Freezing of gait	Not reliably improved unless it was an “off” phenomenon	Complex, partly non-dopaminergic
Speech and swallowing	Not improved; may worsen slightly	Not dopamine-dependent; stimulation can spread to nearby fibers
Memory and thinking	Not improved; verbal fluency may decline	Cortical networks unaffected by target
Mood, apathy, anxiety	Not a target; changes possible in either direction	Limbic circuits, medication shifts, adjustment period
Constipation, blood pressure, bladder	Not improved	Autonomic nervous system, outside the target
Disease progression	Not slowed or halted	DBS treats symptoms; it does not protect neurons

Two patterns stand out. Everything in the top half of the table shares a dopamine link, and everything in the bottom half does not. If you remember nothing else, remember that the best predictor of your own outcome is how you move during your best hour on medication, minus the tremor exception.

Who is a candidate for DBS, and who is usually asked to wait

DBS is not offered at diagnosis, and it is not held back until every other option fails. It sits in a fairly well-defined middle zone.

People typically considered, according to Mayo Clinic and NHS guidance, have had Parkinson disease for several years, still get a clear benefit from levodopa, and yet experience troublesome motor fluctuations, dyskinesia or medication-resistant tremor despite their team’s best efforts to adjust medicines. They are in reasonable general health for surgery, do not have dementia, and have realistic goals that line up with what stimulation can deliver.

The evaluation itself is a multi-visit process rather than a single appointment. It usually includes a formal “off” and “on” motor examination, where the person is assessed after withholding medication overnight and again after a dose, to quantify dopamine-responsiveness. Neuropsychological testing checks memory, attention and mood. Brain MRI rules out other explanations for symptoms and maps the target. A psychiatrist or psychologist may screen for depression and impulse-control problems. Only after that does a multidisciplinary team recommend for or against surgery and choose a target.

Several groups are commonly asked to wait or are not offered DBS. People whose symptoms are still well controlled with medicine gain little from surgery and carry all of its risks. Those whose main complaints are balance, freezing or speech are unlikely to benefit for the reasons already described. Established dementia, untreated severe depression or psychosis, and medical conditions that make anesthesia or neurosurgery hazardous are also usual reasons to hold off. Doubt about the diagnosis, for example when features suggest an atypical parkinsonian syndrome rather than Parkinson disease, is another, because those conditions respond poorly to stimulation.

Age alone is not a firm cutoff, though many teams weigh it alongside overall health and cognitive reserve. The decision always rests with the treating team and the person together.

DBS vs medication for Parkinson's: partners, not rivals

A common misunderstanding frames the choice as surgery or pills. In practice, nearly everyone who has DBS continues to take Parkinson medication, and the two work best in combination.

Medication supplies dopamine the brain can no longer make in sufficient quantity, or mimics its action. It treats the widest range of motor symptoms and remains the foundation of care at every stage, as NHS guidance emphasizes. Its weakness is delivery: tablets produce peaks and troughs, and over years the brain becomes less able to buffer those swings, which is what creates fluctuations and dyskinesia.

Stimulation does not supply dopamine at all. It quiets the downstream circuit that misbehaves when dopamine is low. Its strength is constancy; the pulses run twenty-four hours a day, unaffected by meals, protein intake or a forgotten dose. Its weakness is reach: it only helps symptoms routed through the stimulated network.

Put together, stimulation provides a steady floor of control while medication, often at an adjusted level set by the neurologist, provides the fine tuning. Many people describe the combination as returning them to how their medication felt in the earlier years, before the swings became severe. That is the realistic aim: recovering the best “on” state and making it last through more of the day, not exceeding it.

Other options exist and deserve mention in any balanced discussion. Continuous medication delivery systems, such as pumps that deliver a dopamine-related medicine under the skin or into the small intestine, address fluctuations without brain surgery and suit some people better. Focused ultrasound, which creates a precise lesion without an incision, is used mainly for tremor and treats one side of the body. A movement disorders team can lay these out neutrally against DBS for a given individual; no single option is right for everyone.

What the days and weeks after DBS surgery usually look like

People are often surprised to learn that the operation is not the moment the benefit begins.

Surgery itself is usually done in one or two stages: lead placement in the brain, followed by generator placement under the collarbone, sometimes on the same day and sometimes a week or two apart. Mayo Clinic describes the generator being implanted and then activated only after healing has begun. Hospital stays are typically short, often a night or two after lead placement, though this varies by center and by how the person recovers.

The first days at home involve small scalp and chest incisions to keep clean and dry, some headache or scalp soreness, fatigue, and occasionally a curious phenomenon called the microlesion effect, in which symptoms temporarily improve before the device is even turned on because of mild swelling around the lead. That fades over days to a couple of weeks and should not be mistaken for the final result.

Initial programming generally takes place a few weeks after surgery, once swelling has settled. Mayo Clinic notes that the device is turned on in a clinic visit and settings are adjusted over subsequent appointments. This is the phase that demands patience. A programmer tests each contact on the lead, finds the combination that best calms symptoms without causing tingling, muscle pulling or speech change, and then adjusts medication in coordination with the neurologist. Reaching a stable setting commonly takes several visits spread over a few months.

Beyond that, follow-up becomes routine: periodic checks, occasional fine tuning as the disease slowly evolves, and eventual battery replacement. Cleveland Clinic reports that non-rechargeable generators typically last around three to five years before a minor outpatient procedure to replace them, while rechargeable versions can last considerably longer with regular home charging. Timelines are typical ranges, not guarantees, and your own team’s schedule takes precedence.

Risks and side effects of deep brain stimulation in plain language

Brain surgery carries real risks, and honest counseling names them without either minimizing or dramatizing.

The most serious surgical complication is bleeding in the brain, which can cause a stroke. Mayo Clinic lists this along with infection, and both are uncommon but not rare enough to ignore. Infection may involve the scalp, the chest pocket or the hardware itself, and if it takes hold in the device the system sometimes has to be removed and later replaced. Other surgical issues include the lead shifting from its intended position, wire breakage, seizure around the time of surgery, breathing difficulties and, rarely, heart problems related to anesthesia.

Stimulation-related effects are a separate category, and their defining feature is that most are adjustable. When current spreads beyond the intended target it can produce tingling or numbness, tightening of face or limb muscles, double vision, slurred speech, imbalance, lightheadedness or mood shifts. Cleveland Clinic and Mayo Clinic both list these. A programmer can usually reduce or eliminate them by changing the active contact or the intensity, sometimes at the cost of a little benefit.

Longer-term concerns include the cognitive changes described earlier, weight gain that some people notice in the first year, and the practical realities of living with implanted hardware: keeping devices such as certain MRI scanners, diathermy and strong magnets in mind, and carrying identification. Many modern systems are MRI-conditional, meaning scans are possible under specific conditions; this must always be checked with the DBS team before any imaging.

Finally there is the risk of disappointment. When expectations exceed what the device can do, particularly around balance, speech or thinking, the result can feel like failure even when tremor and fluctuations have improved. The single best protection against this is the frank conversation this article is trying to model.

What people often get wrong about DBS

Several durable myths circulate about DBS. Correcting them is part of good preparation.

“DBS is a last resort.” Waiting until a person is severely disabled, has developed dementia or has lost their response to levodopa tends to remove them from candidacy altogether. The window of benefit is a middle window, as described by NINDS and Mayo Clinic: still responsive to medication, but troubled by fluctuations or tremor that medicine cannot manage.

“It slows the disease.” No current evidence shows that stimulation protects dopamine-producing cells or delays progression. DBS is symptomatic treatment. Parkinson disease continues at its own pace beneath the improved control, which is why programming is revisited over the years.

“It replaces medication.” Medicines are usually continued, often at adjusted levels chosen by the neurologist. Stopping them independently after surgery is unsafe and not something to attempt.

“It burns part of the brain.” That describes older lesioning procedures and modern focused ultrasound. DBS is non-destructive, adjustable and reversible; the device can be switched off or removed.

“Being awake means you will feel the surgery.” The brain itself has no pain receptors. When part of the operation is done awake, local anesthesia numbs the scalp, and the awake portion allows the team to test stimulation safely. Many centers now also offer fully asleep placement.

“It will fix my walking and speech.” As the table above shows, these are the areas where evidence is weakest and where mild worsening is possible.

“If it works, it works immediately and forever.” Tremor may settle quickly once the device is on, but the full, stable result unfolds over months of programming, and periodic adjustments continue for as long as the device is in place.

“Everyone with Parkinson disease is eligible.” A structured evaluation screens carefully, and a meaningful share of referred people are advised that another approach suits them better.

Questions to ask your care team before deciding

A DBS decision is easier to live with when you have asked the right questions and heard specific answers. Bring this list, and write down what you are told.

• Based on my “off” and “on” examination, which of my symptoms do you expect to improve, and which do you expect to stay the same or possibly worsen?
• What is my main goal for surgery, and does the evidence support DBS for that goal?
• Which target do you recommend for me, subthalamic nucleus or globus pallidus, and why?
• Will the operation be done awake, asleep or in stages, and what does each involve here?
• What are my personal risk factors for bleeding, infection or confusion after surgery?
• What did my neuropsychological testing show, and how does it affect the recommendation?
• How will my medication plan change after surgery, and who will manage those changes?
• How many programming visits should I expect, and roughly over what period?
• Who do I call if a symptom suddenly changes or the device seems to stop working?
• Which type of generator is suggested, rechargeable or non-rechargeable, and what does each mean for me day to day?
• What are the rules for MRI, airport security, dental work and other medical procedures once the device is in place?
• What are my alternatives, including continuous medication delivery and focused ultrasound, and how do they compare for my particular symptoms?
• If I decide to wait, what signs would suggest it is time to revisit the decision?
• Is there a person or family who has been through this at your center who would be willing to talk with me?

Notice how many of these questions concern the team’s process rather than the device. Outcomes in DBS depend heavily on evaluation, surgical precision and long-term programming, so understanding how your team works is as informative as any statistic.

When to call your doctor

Most of the DBS journey unfolds at a measured pace, but a few situations call for prompt contact with the care team or emergency services.

Seek emergency care immediately for signs of stroke or brain bleeding after surgery: sudden severe headache, new weakness or numbness on one side of the body, drooping of the face, trouble speaking or understanding speech, sudden vision loss, a seizure, or new confusion or drowsiness that is out of character. These can occur in the first days after lead placement and must not be watched at home.

Call the DBS team the same day for redness, warmth, swelling, tenderness or discharge at the scalp or chest incision, or a fever without an obvious cause, since hardware infection is easier to manage when caught early. The same applies to skin over the wire or generator that looks thin, dusky or is breaking down.

Contact the team promptly, rather than waiting for the next scheduled visit, if there is a sudden return of tremor, stiffness or slowness, which can signal a device fault, battery depletion or a lead problem; new or worsening double vision, slurred speech, muscle tightening, tingling or imbalance, which often mean stimulation needs adjustment; or a marked change in mood or behavior, including new depression, thoughts of self-harm, unusual impulsivity, hallucinations or severe apathy. Any thoughts of suicide warrant immediate help through emergency services or a crisis line.

Tell the team before any MRI, surgery, cardiac procedure or physical therapy involving electrical or heat-based equipment, and carry your device identification card so other clinicians can check compatibility.

Finally, if you are considering DBS and your symptoms are changing faster than expected, or you are struggling with severe “off” periods, falls or swallowing difficulty, ask for an earlier review. Timing shapes candidacy, and the treating team is best placed to judge when to move forward.

Frequently asked questions

What symptoms does DBS improve most in Parkinson disease?

Tremor, rigidity, slowness, wearing-off between doses and medication-related dyskinesia are the symptoms most consistently improved. These share a common thread: they are driven by the dopamine-dependent motor circuit where the electrode sits. NINDS and Mayo Clinic identify these fluctuating motor symptoms as the core reasons DBS is offered. Symptoms outside that circuit respond much less predictably.

Does DBS help balance and prevent falls?

Generally no. Balance and postural instability depend on brainstem and cortical circuits outside the stimulated target, and they usually persist even when medication is at its best. DBS can indirectly steady walking that was fluctuating with medication, but it does not repair a failing balance system, and both Mayo Clinic and Cleveland Clinic list balance problems among possible side effects. Physical therapy remains the main approach.

Who is a candidate for DBS surgery?

Typical candidates have had Parkinson disease for several years, still respond clearly to levodopa, yet have troublesome fluctuations, dyskinesia or medication-resistant tremor. They are medically fit for neurosurgery, free of dementia and have realistic goals. A movement disorders team confirms this through off-and-on motor testing, neuropsychological assessment and brain imaging before recommending surgery, and the decision is made jointly.

How does DBS compare with medication for Parkinson's?

They work differently and are used together. Medication supplies or mimics dopamine and treats the widest range of symptoms but produces peaks and troughs. Stimulation quiets the downstream motor circuit continuously, independent of dose timing, but only reaches dopamine-linked symptoms. Most people continue medicines after surgery at levels set by their neurologist, aiming to recover their best on state for more of the day.

Will DBS slow down my Parkinson disease?

No. DBS is a symptomatic treatment; there is no evidence that it protects dopamine-producing neurons or delays progression. The disease continues at its own pace beneath the improved control, which is why stimulation settings are revisited over the years and why some symptoms, particularly balance and speech, may still advance despite good tremor control.

Can DBS affect speech or memory?

It can. Speech may become softer or less clear in some people, and programmers often adjust settings to limit this. Large studies summarized by NINDS show most people without dementia keep their overall cognitive function, but verbal fluency, the speed of producing words, is the domain that most commonly declines. People with established dementia are usually not offered DBS.

How soon after DBS surgery does it start working?

The device is usually switched on a few weeks after surgery, once swelling has settled, according to Mayo Clinic. Tremor may quiet quickly at that first session, but the full result emerges over several programming visits spread across a few months, alongside medication adjustments made by the neurologist. A brief temporary improvement right after surgery, before activation, is a known swelling effect and not the final outcome.

Is DBS surgery done while you are awake?

Often part of it is, so the team can test stimulation while you move or speak, but the scalp is numbed and the brain itself has no pain receptors. Many centers also perform fully asleep placement guided by imaging alone. Both are standard approaches, and the choice depends on the center’s practice and your individual situation, which your surgical team will explain.

What are the main risks of deep brain stimulation?

Surgical risks include brain bleeding or stroke, infection of the wound or hardware, seizure, lead displacement and anesthesia-related problems; Mayo Clinic lists these as uncommon but serious. Stimulation-related effects such as tingling, muscle pulling, double vision, slurred speech, imbalance and mood change are usually adjustable through programming. Cognitive change, weight gain and living with implanted hardware are longer-term considerations.

How long does the DBS battery last and what happens when it runs out?

Cleveland Clinic reports that non-rechargeable pulse generators typically last around three to five years, while rechargeable versions can last considerably longer with regular home charging. Replacement is a minor outpatient procedure involving the chest pocket only, not the brain leads. A sudden return of symptoms can signal a depleted battery and should prompt a call to the DBS team.

References

• NINDS (NIH): Parkinson's Disease
• NHS: Parkinson's disease, Treatment
• Cleveland Clinic: Deep Brain Stimulation
• MedlinePlus: Deep brain stimulation

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.